Editor LSA

Investor's Alert - Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR), SanDisk Corporation (NASDAQ:SNDK), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Netflix, Inc. (NASDAQ:NFLX)

 

Lewes, DE -- (SBWIRE) -- 10/03/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR), SanDisk Corporation (NASDAQ:SNDK), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Netflix, Inc. (NASDAQ:NFLX).

Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR) opened its last trade at the price of $75.37. Its closing price was $75.46 after losing -1.97% for the day. The company traded with the total volume of 4.66 million shares, while its average trading volume remained 4.00 million shares. The beta of this stock stands at 0.91. Green Mountain Coffee Roasters, Inc. engages in the specialty coffee and coffeemaker businesses in the United States and Canada.

Will GMCR Get Buyers Even After The Recent Rally? Find Out Here

SanDisk Corporation (NASDAQ:SNDK) percentage change surged 2.35% to close at $41.48 with the total traded volume of 4.61 million shares while its average volume of 3.33 million shares. The 52 week range of the stock remained $38.47 - $63.97, while its day lowest price was $59.65. The share price hit the day highest price of $61.94. Sandisk Corporation designs, develops, manufactures, and markets flash storage card products that are used in various consumer electronics products.

Will SNDK Continue To Move Higher? Find Out Here

Celldex Therapeutics, Inc. (NASDAQ:CLDX) traded on volume of 4.52 million shares in the last session against average volume of 2.41 million shares. The company started its trading session with the price of $38.21 and closed at $36.71 by scoring -2.96%. In the last three months the stock was up 99.84% while its 52 week ranges of the stock were $5.02 - $38.84. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.

Will CLDX Continue To Move Higher? Find Out Here

Netflix, Inc. (NASDAQ:NFLX) started its last trading session with the price of $322.09 and closed at $330.73 by scoring 1.88%. The stock traded with total volume of 4.38 million shares, while the average trading volume remained 2.90 million shares. The beta value of this stock stands at 0.78. Day range for the stock was $321.62 and $333.60. Netflix, Inc. provides Internet television network service that enables subscribers to stream TV shows and movies directly on TVs, computers, and mobile devices in the United States and internationally.

Will NFLX Continue To Move Higher? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/